ALI FARAZ (Chief Executive Officer) sold 4.6% of their position (14.53K shares) of TENAYA THERAPEUTICS, INC. on the open market
Open‑market sale worth $18.2K — a minor trim. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 3 sales
Filed: 8/18/2025ACC: 0001667937-25-000006
DirectorOfficer· Chief Executive Officer
Since Jul 2021
-14.53K
Net shares
Net seller
$18.2K
Total sold
3
Open market trades
0B · 3S
3
Total transactions
14.53K disposed
Non-Derivative Transactions3
Common Stock
Direct
Shares
−5.72K
Price / share
$1.25
Trade value
$7.17K
% of position
1.8%
8/18/2025
317.32K→311.61K
Common Stock
Direct
Shares
−3.89K
Price / share
$1.25
Trade value
$4.88K
% of position
1.2%
8/18/2025
311.61K→307.71K
Common Stock
Direct
Shares
−4.92K
Price / share
$1.25
Trade value
$6.16K
% of position
1.6%
8/18/2025
307.71K→302.79K
Total
Net shares
−14.53K
Net value
-$18.21K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 8/18/2025 | S · Sale | −5.72K | $1.25 | $7.17K | 1.8% | 317.32K | 311.61K |
| Common Stock Direct | 8/18/2025 | S · Sale | −3.89K | $1.25 | $4.88K | 1.2% | 311.61K | 307.71K |
| Common Stock Direct | 8/18/2025 | S · Sale | −4.92K | $1.25 | $6.16K | 1.6% | 307.71K | 302.79K |
| Total | −14.53K | -$18.21K | ||||||
Derivative Transactions0
No derivative transactions reported